2BBBullish & Bearish
Revvity, Inc. Common Stock (RVTY) trades on NYSE. It operates in the Health Care sector, Diagnostics & Research industry. Its current 2BB score is 31 out of 100.
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
Revvity, Inc. Common Stock’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 42 | Normal |
| Quality | 100 | Very Strong |
| Risk | 0 | Very Low |
| CEO | Prahlad Singh |
| Headquarters | Waltham, Massachusetts, United States |
| Founded | 1947 |
| Employees | 11K |
| 52-week range | $81.22 – $118.30 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-01 | — | 1.6609 | — | $779.42M |
| 2026-10-26 | — | 1.3189 | — | $712.06M |
| 2026-08-04 | 1.41 | 1.2468 | $729.69M | $723.22M |
| 2026-04-27 | — | 1.0424 | — | $716.92M |